The global sterility indicators market was valued at USD 547.5 million in 2017 in terms of revenue. It is expected to grow at a CAGR of 10.8% during the forecast period. Stringent regulations regarding healthcare products and greater emphasis on sterility parameters and methods for the prevention of Hospital Acquired Infections are anticipated to drive the global sterility indicator market growth.
|Market||Sterility Indicators Market|
|Analysis Period||2018 - 2026|
|Forecast Data||2018 - 2026|
|Segments Covered||By Type, By Technique, By End-user and By Geography|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Cantel Medical Corporation; Getinge AB; Cardinal Health Inc.; 3M Company; Matachana Group; Mesa Laboratories; and Anderson Products Inc.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
|Customization Scope||10 hrs of free customization and expert consultation|
Increased research and development activities and stringent government regulations and standards are among the factors likely to drive the growth of global sterility indicators market. Additionally, increasing demand for medicines and medical devices owing to high occurrence of chronic diseases such as diabetes, asthma, arthritis and cancer is expected to encourage the global sterility indicator market growth in near future.
Consistent manufacturing protocols, introduction of novel products, and acceptance of modern technologies has led to synchronization of quality and sterility testing standards in the healthcare industry. This factor has shaped a requirement for aseptic manufacturing techniques and also for more efficient and dependable sterilization monitoring process. Additionally, many organizations such as the Agency for Healthcare Research and Quality and Centers for Medicare and Medicaid Services are also promoting awareness about the need for strict regulations for quality and safety testing services of healthcare products. Many of these factors anticipate driving of the expansion of the global sterility indicators market during the forecast period.
Market By Type
Market By Technique
Market By End-user
Market By Geography
In 2017, biological indicator segment among the sterility indicator type, captured the larger market share. Widespread usage comparatively to chemical indicators owing to its dependability is anticipated to propel the segment growth during the forecast period.
North America sterility indicator market is anticipated to continue its dominance with greater market share during the forecast period due to the presence of a large number of established companies and a greater adoption of advanced technologies in the market among the consumers. Asia Pacific sterility indicator market is accounted to exhibit a significant CAGR over the forecast period. Existence of most of the untapped market and abundance availability of supportive government regulations and standards are expected to attract global players in the region.
Some of the major players in the global sterility indicators market include Cantel Medical Corporation; Getinge AB; Cardinal Health Inc.; 3M Company; Matachana Group; Mesa Laboratories; and Anderson Products Inc. The global players are continuously investing in R&D and innovating new product portfolio to attract more and more business opportunity from the emerging nation such as China and India. Players are also involved in merger and acquisition, strategic partnership in order to sustain in the competitive market and to build a competitive shield again the competitors. Additionally, changing customers’ needs are encouraging global players to develop innovative technology solution to cater best to the market. Also, increasing R&D investments coupled with technological advancements to commercialise highly efficient products are anticipated to offer lucrative opportunities for industry participants. Majority of the companies are focusing on continuous product development and offering products at competitive prices, especially in developing countries due to the stern competition from local manufacturers.